Dashboard
Manage Tickers

ALVOAlvotech

Nasdaq alvotech.com


$ 12.11 $ 0.16 (1.33 %)    

Friday, 28-Jun-2024 15:59:36 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 12.16
$ 11.86
$ 0.00 x 0
$ 12.15 x 200
$ 11.84 - $ 12.11
$ 6.70 - $ 18.00
167,044
na
3.24B
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alvotech-received-conversion-notices-for-majority-of-convertible-bonds-into-ordinary-shares-at-the-fixed-conversion-price-of-1000-per-share-prior-to-maturity-date-of-july-1-2024
Alvotech Received Conversion Notices for M...
06/26/2024 08:56:24

alvotech-inks-commercialization-agreement-with-advanz-pharma-for-proposed-biosimilar-to-eylea-ldhd-in-europe
Alvotech Inks Commercialization Agreement ...
06/18/2024 08:09:08

Advanz Pharma secures rights to commercialize Alvotech's biosimilar candidate for Eylea® in Europe Advanz Pharma will le...

alvotech-sa-may-offer-and-sell-ordinary-shares-of-up-to-75m-from-time-to-time-entered-into-open-market-sale-agreement-with-jefferies-relating-to-sale-of-ordinary-shares
Alvotech SA May Offer And Sell Ordinary Sh...
06/14/2024 20:38:28

- SEC Filing

alvotech-and-stada-extend-partnership-through-avt03-biosimilar-candidate-addition
Alvotech And STADA Extend Partnership Thro...
06/11/2024 08:17:36

Under the terms of the agreement, Alvotech will be responsible for development and manufacturing at its state-of-the-art facili...

alvotech-secures-965m-refinancing-deal-to-boost-financial-flexibility-and-support-product-launches
Alvotech Secures $965M Refinancing Deal to...
06/07/2024 08:03:12

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

barclays-maintains-overweight-on-alvotech-raises-price-target-to-22
Barclays Maintains Overweight on Alvotech,...
05/24/2024 15:03:19

Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and raises the price target from $20 to $22.

alvotech-now-sees-fy24-revenue-of-400m-500m-est-318575m
Alvotech Now Sees FY24 Revenue Of $400M-$5...
05/21/2024 21:33:10

Alvotech tightened guidance for EBIDTA to $100 - $150 million for the full year.

alvotech-q1-2024-sales-36894m-miss-45000m-estimate
Alvotech Q1 2024 Sales $36.894M Miss $45.0...
05/21/2024 21:22:29

alvotech-q1-2024-gaap-eps-089-up-from-124-yoy
Alvotech Q1 2024 GAAP EPS $(0.89) Up From ...
05/21/2024 21:20:08

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.89) per share. This is a 28.23 percent increase over losses of $(1.24) ...

stocks-hold-steady-on-mixed-fed-remarks-first-solar-rallies-bitcoin-falls-below-70000-whats-driving-markets-tuesday
Stocks Hold Steady On Mixed Fed Remarks, F...
05/21/2024 16:42:40

It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.

Core News & Articles
Alvotech And Dr. Reddy's Enter Collaborato...
05/21/2024 12:05:27

Core News & Articles
Reported Earlier, Teva And Alvotech Announ...
05/21/2024 06:57:27

alvotech-announced-positive-topline-results-from-a-confirmatory-clinical-study-for-avt05-alvotechs-proposed-biosimilar-to-simponi-and-simponi-aria-golimumab
Alvotech Announced Positive Topline Result...
04/24/2024 08:02:35

fifth-third-bancorp-reports-upbeat-earnings-joins-metropolitan-bank-holding-paramount-global-and-other-big-stocks-moving-higher-on-friday
Fifth Third Bancorp Reports Upbeat Earning...
04/19/2024 14:40:21

Core News & Articles
Alvotech Inks Long-Term Agreement With A S...
04/19/2024 10:11:54

"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing...

Core News & Articles
Alvotech, Teva Announce US FDA Approval Of...
04/16/2024 21:33:05

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of SELARSDI ...

alvotech-receives-fda-approval-for-selarsdi-for-moderate-to-severe-plaque-psoriasis
Alvotech Receives FDA Approval For Selarsd...
04/16/2024 19:46:42

Alvotech receives FDA approval for Selarsdi for moderate to severe plaque psoriasisAdult patients with:moderate to severe plaqu...

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday
Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

alvotech-announces-increased-the-companys-share-capital-by-an-amount-of-130k-by-issuing-13m-ordinary-shares
Alvotech Announces Increased The Company's...
03/22/2024 20:24:51

Alvotech (NASDAQ:ALVO) (the "Company"), a global biotech company specializing in the development and manufacture of bio...

barclays-maintains-overweight-on-alvotech-raises-price-target-to-20
Barclays Maintains Overweight on Alvotech,...
03/22/2024 10:42:15

Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and raises the price target from $17 to $20.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)